Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1312
Gene Symbol: COMT
COMT
0.010 GeneticVariation phenotype BEFREE 1 COMT gene-linked locus that was associated with PE symptoms in the present study, rs4680, is a well-documented functional polymorphism that causes a valine-to-methionine substitution. 29198511 2017
Entrez Id: 351
Gene Symbol: APP
APP
0.020 AlteredExpression phenotype BEFREE Among them, GGT1, LAMC1, and APP were significantly higher in the PE group. 27538475 2018
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation. 19549114 2010
Entrez Id: 5021
Gene Symbol: OXTR
OXTR
0.050 Biomarker phenotype BEFREE Antagonists of the OTR have been reported to inhibit ejaculation in animal models and serve as a potential treatment for premature ejaculation (PE). 31223461 2019
Entrez Id: 5021
Gene Symbol: OXTR
OXTR
0.050 Biomarker phenotype BEFREE Cligosiban is an orally administered oxytocin receptor antagonist being developed to treat premature ejaculation (PE). 31351659 2019
Entrez Id: 5021
Gene Symbol: OXTR
OXTR
0.050 Biomarker phenotype BEFREE Cligosiban is an orally administered, centrally penetrant oxytocin receptor antagonist being developed to treat premature ejaculation (PE). 31351660 2019
Entrez Id: 5021
Gene Symbol: OXTR
OXTR
0.050 Biomarker phenotype BEFREE Cligosiban is well tolerated over a wide dose range, and has the pharmacokinetic properties to be taken as required prior to sexual intercourse in men with PE and to antagonize the oxytocin receptor in the brain and spinal cord. 30341006 2018
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE Here, we evaluated the relationship between a polymorphism in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and the response of patients with premature ejaculation to SSRI medication. 25518026 2014
Entrez Id: 367
Gene Symbol: AR
AR
0.010 GeneticVariation phenotype BEFREE In this study, we investigate the combinatorial effects of trinucleotide repeats of androgen receptor and allelic variants of the 5-HTTLPR gene on sex steroids, hypophyseal hormones, sexual performance, and premature ejaculation assessment parameters among evidence-based lifelong premature ejaculation subjects. 30019487 2018
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE In this study, we investigate the combinatorial effects of trinucleotide repeats of androgen receptor and allelic variants of the 5-HTTLPR gene on sex steroids, hypophyseal hormones, sexual performance, and premature ejaculation assessment parameters among evidence-based lifelong premature ejaculation subjects. 30019487 2018
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE Intravaginal ejaculatory latency time was measured by stopwatch in order to diagnose PE, and the results of the SLC6A4 polymorphisms analysis in PE patients was compared with the control group. 22489680 2012
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE Measurement errors in polymerase chain reaction are a confounding factor for a correct interpretation of 5-HTTLPR polymorphism effects on lifelong premature ejaculation: a critical analysis of a previously published meta-analysis of six studies. 24595335 2014
Entrez Id: 3358
Gene Symbol: HTR2C
HTR2C
0.010 GeneticVariation phenotype BEFREE Our findings indicated that polymorphisms in the 5-HT(2C) receptor gene are associated with LPE, and men who carry the -759T or -697C genotype have increased odds of premature ejaculation. 20453482 2010
Entrez Id: 6462
Gene Symbol: SHBG
SHBG
0.010 Biomarker phenotype BEFREE Particularly, compared with controls, hyperthyroid patients have higher serum SHBG and lower free and bioavailable testosterone concentrations, a higher rate of astheno-zoospermia, oligo-zoospermia, and terato-zoospermia, and a higher prevalence of sexual disturbances, such as premature ejaculation. 28429281 2017
Entrez Id: 351
Gene Symbol: APP
APP
0.020 AlteredExpression phenotype BEFREE Patients with PE presented 1.5-fold higher levels of APP (P = .004) than control subjects. 28065363 2017
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 Biomarker phenotype BEFREE Previously conducted studies have found contradicting results regarding the possible role of 5-HTTLPR in premature ejaculation. 22810993 2013
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE Recently, genetic polymorphisms located on SLC6A4 gene codifying for 5-HT transporter (5-HTT), the major regulator of serotonic neurotransmission, have been linked with the pathogenesis and risk of PE. 23383022 2013
Entrez Id: 338340
Gene Symbol: MMS
MMS
0.010 Biomarker phenotype BEFREE The advantage of ICD-11-MMS is the inclusion of a third PE subtype, which is congruent with Subjective PE. 30659291 2019
Entrez Id: 6532
Gene Symbol: SLC6A4
SLC6A4
0.090 GeneticVariation phenotype BEFREE The short (S) allele of the 5-HTTLPR gene was significantly more frequent in PE patients than in controls (P<0.05). 19252508 2009
Entrez Id: 8654
Gene Symbol: PDE5A
PDE5A
0.010 Biomarker phenotype BEFREE The specific PDE5 inhibitors, particularly sildenafil and tadalafil, are prescribed for erectile dysfunction, as well as pulmonary hypertension, lower urinary tract symptoms, and premature ejaculation. 29256125 2017
Entrez Id: 2324
Gene Symbol: FLT4
FLT4
0.010 GeneticVariation phenotype BEFREE The subjects were assessed by the Mini-International Neuropsychiatric Interview (MINI) and self-report questionnaires: PCL-5, i.e., PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) with Criterion A, International Index of Erectile Function (IIEF), Premature Ejaculation Diagnostic Tool (PEDT), and Relationship Assessment Scale (RAS). 30934864 2019
Entrez Id: 9033
Gene Symbol: PKD2L1
PKD2L1
0.010 GeneticVariation phenotype BEFREE The subjects were assessed by the Mini-International Neuropsychiatric Interview (MINI) and self-report questionnaires: PCL-5, i.e., PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) with Criterion A, International Index of Erectile Function (IIEF), Premature Ejaculation Diagnostic Tool (PEDT), and Relationship Assessment Scale (RAS). 30934864 2019
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.020 Biomarker phenotype BEFREE This study concluded that there was no disturbance in serum levels of testosterone, gonadotropins and prolactin in patients with PE and controls. 28439908 2018
Entrez Id: 5617
Gene Symbol: PRL
PRL
0.020 AlteredExpression phenotype BEFREE Thyroid-stimulating hormone, luteinizing hormone, and prolactin levels were significantly lower in men with premature ejaculation according to premature ejaculation diagnostic tool (p=0.017, 0.007 and 0.007, respectively). 27619666 2017
Entrez Id: 5021
Gene Symbol: OXTR
OXTR
0.050 Biomarker phenotype BEFREE To assess the efficacy and safety of the selective oxytocin receptor antagonist epelsiban in the treatment of premature ejaculation (PE). 23937679 2013